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Background: Exercise capacity after heart trans-
plantation (HTx) remains limited despite normal
left ventricular systolic function of the allograft.
Various clinical and haemodynamic parameters
are predictive of exercise capacity following
HTx. However, the predictive significance of
chronotropic competence has not been demon-
strated unequivocally despite its immediate rele-
vance for cardiac output.
Aims:This study assesses the predictive value of
various clinical and haemodynamic parameters for
exercise capacity in HTx recipients with complete
chronotropic competence evolving within the first
6 postoperative months.
Methods: 51 patients were enrolled in this exer-
cise study. Patients were included when at least >6
months after HTx and without negative
chronotropic medication or factors limiting exer-
cise capacity such as significant transplant vascu-
lopathy or allograft rejection. Clinical parameters
were obtained by chart review, haemodynamic pa-
rameters from current cardiac catheterisation, and
exercise capacity was assessed by treadmill stress
testing. A stepwise multiple regression model
analysed the proportion of the variance explained
by the predictive parameters.
Results: The mean age of these 51 HTx recipi-
ents was 55.4 ± 13.2 yrs on inclusion, 42 pts were
male and the mean time interval after cardiac trans-
plantation was 5.1 ± 2.8 yrs. Five independent pre-
dictors explained 47.5% of the variance observed
for peak exercise capacity (adjusted R
2
= 0.475). In
detail, heart rate response explained 31.6%, male
gender 5.2%, age 4.1%, pulmonary vascular resist-
ance 3.7%, and body-mass index 2.9%.
Conclusion: Heart rate response is one of the
most important predictors of exercise capacity in
HTx recipients with complete chronotropic com-
petence and without relevant transplant vasculopa-
thy or acute allograft rejection.
Key words: heart transplantation; heart rate; exer-
cise capacity
Summary
Long-term outcome following cardiac trans-
plantation has substantially improved since the first
successful transplantation in 1967 at the Groote
SchuurHospital inCapeTown [1].Careful recipient
anddonorselection,advances in immunosuppressive
medication and treatment tailored to the individual
recipient provided the basis for a 10-year survival of
72% inHTx recipients in Bern [2]. Quality of life is
the most important clinical parameter after cardiac
transplantation [3], and for many HTx recipients it
is closely related to postoperative improvement in
physical performance [4]. However, exercise capac-
ity afterHTx often remains reduced to levels seen in
stable heart failure patients [5, 6, 9, 11], and consid-
erably lower when compared with matched healthy
controls [12,andref.there].Nevertheless,someHTx
recipients achieve more than 90% of their age-pre-
dicted exercise capacity level [7, 13], and even ascent
of the Matterhorn (4,478 m above sea level) is re-
ported [14].
Factors related to impaired exercise capacity
after HTx are chronotropic incompetence due to
cardiac denervation [8, 12, 15–20], diastolic dys-
function of the cardiac allograft [10, 19] or muscu-
lar deconditioning and metabolism of the skeletal
muscle posttransplant [20–23]. Identified predictive
variables for exercise performance after HTx are
age, gender, body mass index (BMI), duration of in-
tensive care unit treatment after HTx, pulmonary
vascular resistance and maximum systolic blood
pressure [13, 24–26]. The predictive value of exer-
cise-induced heart rate increase, however, has not
been demonstrated unequivocally [13, 24–27] de-
spite its direct relevance for cardiac output [28].
Chronotropic competence evolves in the cardiac al-
lograft within the first 6 postoperative months [29],
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suggesting that patients with a shorter posttrans-
plant time interval may present with incomplete
chronotropic competence.This study tests the pre-
dictive significance of heart rate increase for exer-
cise capacity in stable HTx recipients more than
6 months posttransplant.
Methods
Study design, setting and participants
The present study enrolled orthotopic heart transplan-
tation (HTx) recipients followed at the HTx outpatient
clinic of Bern University Hospital. Patients were screened
when hospitalised for their annual posttransplant follow-up,
which includes right and left heart catheterization, histolog-
ical monitoring of allograft rejection and treadmill exercise
testing. Patients were screened when >6 months posttrans-
plant, and after informed consent had been obtained. Ex-
clusion criteria were (1) current allograft rejection ≥4/II
(Texas score / ISHLT) within the last 4 weeks, and (2) rele-
vant macroscopic coronary artery disease with >50% steno-
sis in the most recent coronary angiogram because both
may affect exercise capacity; (3) physical inability to per-
form treadmill exercise; (4) systolic left ventricular pump
function <50%; (5) current treatment with negative
chronotropic medication.
Study patients received immunosuppressive medica-
tion (cyclosporine, tacrolimus, azathioprine, mycopheno-
late acid, sirolimus, and prednisone) guided by side effects
and regular histological monitoring of RV endomyocardial
biopsies (postoperative week 1–4: every week; months 2–6:
every 2–4 weeks; months 7–12: every 4–6 weeks; 2nd year:
every 2–3 months; 3rd year: every 4 months; 4th / 5th year:
every 6 months; thereafter: once annually). The study was
approved by the local Ethics Committee (study number
120/2002).
Demographic and clinical data
These were obtained from chart review and included
in the multiple regression model which is described below.
Exercise testing
All patients were familiar with the test procedure and
underwent symptoms-limited exercise stress testing on a
computer-controlled, rotational speed-independent bicycle
(Ergometrics 800S, Ergoline
®
GmbH, Bitz, Germany).
Each test started with baseline measurements at rest during
1 minute, followed by a 3-minute reference phase of cycling
without workload. Thereafter, workload was increased in a
stepwise protocol with 10, 15 or 20 watts workload increase
per minute. The rate of workload increase was chosen on
the basis of age- and gender-predicted values. Study partic-
ipants were monitored continuously, using a 12-lead ECG,
and blood pressure was obtained every other minute.
Exercise capacity was measured in metabolic equiva-
lents (MET [kcal/kg/h]).OneMET is defined as 1 kilocalo-
rie per kilogram per hour and is the caloric consumption of
a human subject while at complete rest. Heart rate at rest,
peak heart rate and blood pressure were recorded. Heart
rate response was calculated by subtracting heart rate at rest
from peak heart rate.
Statistical analysis
All analyses were done in STATA (version 10.0,
STATACorporation,College Station,TX,USA).Measure-
ments and clinical parameters were expressed as mean val-
ues ± one standard deviation (SD), or numbers and percent-
ages, as appropriate. A stepwise multiple regression model
was used to identify the predictive strength of every clinical
or haemodynamic parameter (= independent variable) for
peak exercise measured in METs (= dependent variable).
The outcome of interest in this stepwise multiple regres-
sion analysis was the adjusted R
2
(= variance observed)
which is the proportion of difference observed in the peak
exercise capacity predicted by the independent variables. If
the independent variables perfectly predict maximal exer-
cise capacity, the adjusted R
2
value is 100% or, in other
terms, all of the variance in the maximal exercise capacity
can be explained by the total of the respective variance of
the independent variables. Every other recorded parameter
was added separately as an independent variable into the re-
gression model, together with the a priori variables (age,
sex, body mass index and heart rate response). Parameters
increasing the adjusted R
2
(= predictors) were kept in our
regression model. The final multiple regression model in-
cluded the clinical and haemodynamic parameters which
increased the total adjusted R
2
. Statistical significance was
set at a p-value of <0.05.
Results
Participants
87 HTx recipients were screened. A total of 36
patients were excluded due to a postoperative time
interval shorter than 6 months after HTx (n = 19),
inability to perform treadmill exercise (n = 7), or
treatment with negative chronotropic agents (n =
10). 51 HTx recipients met the inclusion criteria
and entered the final analysis.
Clinical data
Clinical characteristics are shown in table 1. Of
the participants 42 were males and 9 females. End-
stage heart failure resulted from ischaemic car-
diomyopathy (51%), dilated cardiomyopathy
(31%), or some other aetiology (18%).
Exercise capacity and invasive haemodynamic
measurements
Treadmill exercise data are presented in table 2.
The mean peak exercise level was 8.5 MET (range
2.2 to 20.0). The peak exercise level achieved in
men was higher but without statistical significance
(8.8 ± 3.3 vs 7.1 ± 2.2 MET, p = 0.16). Systolic left
ventricular ejection fraction (EF) was normal in all
study participants (table 3). Pulmonary vascular re-
sistance (PVR), left ventricular enddiastolic pres-
sure (LVEDP), and cardiac output (CO) were nor-
mal (table 3).
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Number of patients 51
Demographics
Male/female 42/9
Age at treadmill exercise test, years 55.4 ± 13.2
Age at HTx, years 50.3 ± 12.8
Time posttransplant, years (mean) 5.1 ± 2.8
(range in years) (0.9–16.8)
Etiology of CHF
Ischaemic cardiomyopathy (%) 51
Measurements at HTx
Recipient body weight, kg 75.3 ± 12.3
Donor body weight at transplantation, kg 73.6 ± 10.4
Ischaemic donor time (minutes) 110 ± 45
Risk factors
Diabetes (%) 23
Body mass index (BMI) 25.5 ± 3.9
Dyslipidaemia (%) 15
Hypertension (%) 0
Mean Texas allograft rejection score (ISHLT) 1.4 ± 0.6
Non-immunosuppressive medication
Diuretic (%) 48
b-blocker (%) 0
Amlodipine (%) 69
ACE-I / ARB (%) 67
Table 1
Demographic and
clinical characteris-
tics of study group.
ACE-I: angiotensin
converting enzyme
inhibitor; ARB: an-
giotensin receptor
type II blocker.The
binary variables is-
chaemic cardiomy-
opathy, diabetes,
BMI, dyslipidaemia
and hypertension are
provided in percent
of patients affected
or treated with either
medication (%).
Rest Submaximal Maximal
exercise exercise
level level
MET [kcal/kg/h] 1 6.1 ± 2.6 8.5 ± 3.2
Heart rate [beats/min] 95 ± 12 125 ± 18 137 ± 20
Systolic blood pressure 128 ± 14 156 ± 19 167 ± 22
[mm Hg]
Diastolic blood 86 ± 9 83 ± 11 84 ± 13
pressure [mm Hg]
Table 2
Exercise parameters
(values = mean
± S.D.).
MET: metabolic
equivalent.
Range Mean ± S.D.
EF [%] 49 – 78 62.4 ± 6.8
LVEDP [mm Hg] 2 – 18 8.7 ± 4.1
PVR [dyn·s/cm
5
] 0 – 289 118 ± 54
CO [litres/min] 3.9 – 11.0 6.5 ± 1.5
Table 3
Haemodynamic
parameters.
TEF: ejection fraction;
LVEDP: left ventricu-
lar enddiastolic pres-
sure; PVR: pulmonary
vascular resistance;
CO: cardiac output.
Predictors of exercise capacity
Univariate analysis demonstrated peak exercise
was significantly related to heart rate response
(p = 0.001), peak heart rate (p = 0.005),
recipient age p = 0.009), diuretic treatment
(p = 0.011), PVR (p = 0.018), the presence of dia-
betes (p = 0.021), and the number of episodes
with postoperative right ventricular heart failure
(p = 0.038). BMI (p = 0.09), left ventricular output
(p = 0.147) and gender (p = 0.163) were not signifi-
cantly related. The significance level was greater
than 0.20 for amlodipine medication, peak systolic
blood pressure, time posttransplant, left ventricular
enddiastolic pressure, number of rejection episodes,
aetiology of CHF, dyslipidaemia, donor weight, left
ventricular ejection fraction, medication with an-
giotensin converting enzyme inhibitors or blockers
of the angiotensin type I receptor, immunosuppres-
sive medication, peak diastolic blood pressure and
ischaemic donor time.
Stepwise multivariate linear regression identi-
fied in declining order heart rate response, gender,
age, pulmonary vascular resistance, and BMI as pre-
dictive variables of exercise capacity after HTx
(table 4). Fig. 1 depicts the correlation of the nu-
meric predictors with peak exercise in METs. Alto-
gether, these 5 independent predictors explain
47.5% of variance observed for maximal
exercise. In detail, heart rate response explains
31.6%, while all other variables are less relevant
(gender 5.2%, age 4.1%, PVR 3.7%, and BMI
2.9%).
Independent Added variance Total adjusted R
2
variable explained
Heart rate response 31.6% 0.316
Gender 5.2% 0.368
Age 4.1% 0.409
PVR 3.7% 0.446
BMI 2.9% 0.475
Discussion
Exercise capacity after heart transplantation re-
mains limited for a multiplicity of reasons. This
study identified exercise-induced heart rate increase
as one of the most relevant cardiac predictors of ex-
ercise capacity in HTx recipients who are more
than 6 months posttransplant.
The predictive relevance of chronotropic com-
petence has not been demonstrated unequivocally
in the literature. For instance, peak heart rate was
not predictive of maximal exercise capacity in a
larger study enrolling 174 patients with a postoper-
ative time interval ranging from 0.3 to many years
after HTx [13]. In contrast, chronotropic reserve
was predictive of maximal oxygen uptake in 85HTx
recipients enrolled 1–100 months after transplanta-
tion [27], and in 95 patients studied after the first
postoperative year [24]. Subsumption of these re-
sults is difficult because some patients were on neg-
ative chronotropic medication at the time of exer-
cise testing [24, 27], or were included before
chronotropic competence evolved [13, 27, 29].This
study did not include such HTx recipients, and in
Table 4
Predictors of maximal exercise capacity in 51 heart trans-
plant recipients.
PVR: pulmonary vascular resistance; BMI: body mass index.
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addition, patients with significant transplant vascu-
lopathy or clinically relevant allograft rejection
were excluded from the outset because these factors
may affect exercise heart rate and capacity [23].
In fact, exercise-induced heart rate increase ex-
plained the largest part (31.6%) of the variance ob-
served for peak exercise in this study, thus underlin-
ing the significance of chronotropic competence
for exercise capacity after HTx.This observation is
in accordance with the relevance of heart rate for
the output of the cardiac allograft as demonstrated
in haemodynamic studies [28]. A finding of note is
that peak heart rate was not predictive in this study,
despite its correlation with peak exercise in the uni-
variate analysis. Similar observations are reported
from other studies [13, 24], but peak exercise was
measured in this study by treadmill exercise testing
and therefore we cannot rule out that patients did
not exercise to their maximal peak heart rate.
Multivariate analysis identified four additional
predictors of peak exercise which contribute an-
other 15.9% to explaining the variance observed.
Thus, the five predictors explained together almost
half of the variance (R
2
= 0.475) observed in peak
exercise in this study, in agreement with a result of
the same magnitude (R
2
= 0.51) reported from an-
other exercise study in 174 HTx recipients [13].
The consistency of these results suggests that both
studies may have missed measurement of further
variables important for exercise capacity after HTx,
such as deconditioning of the skeletal muscle, dys-
functional metabolism of the skeletal muscle post-
transplant [20–23], or peripheral blood flow dysreg-
ulation. Nevertheless, even if one of the latter vari-
ables is of considerable predictive significance,
heart rate response should remain important since
in this study it explained almost one third of the
variance observed.
The other four variables predictive of peak ex-
ercise in this study were male gender, explaining
5.2%, age 4.1%, PVR 3.7%, and BMI 2.9%. The
minor relevance of PVR and BMI for exercise ca-
pacity are in accordance with previous reports [13,
24], although age was only of minor relevance in
this study whereas it explained 34% of the variance
observed in the study of Gullestad et al.There is no
complete explanation for this discrepancy, although
differences in the selection criteria or the distribu-
tion of the recipient age within the two study col-
lectives may play a role. In addition, the mean post-
operative time interval of patients enrolled in this
study was longer, and this may have rendered com-
plete chronotropic competence more likely.
Other postoperative variables such as the pres-
ence of diabetes, diuretic treatment and the number
of episodes of acute right ventricular dysfunction
correlated with exercise capacity in univariate
analysis but did not remain significant in the step-
wise multiple linear regression analysis. Ischaemic
donor time, the number of acute allograft rejection
episodes or the aetiology of pretransplant heart dis-
ease were not related to exercise capacity in this
study.These parameters are relevant for short-term
morbidity and mortality after HTx [30], and their
insignificance indirectly suggests the clinical stabil-
ity of the patients included into this study.
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Figure 1
Linear regression be-
tween maximal exer-
cise (maxmet) and
increase in heart rate
(a), age (b) , pul-
monary vascular re-
sistance (c), and BMI
(d) in the 51 HTx re-
cipients included.
Correlations of pre-
dictive variables of
exercise capacity
with exercise capac-
ity. Maxmet: maximal
exercise capacity
measured in meta-
bolic equivalents.
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Limitations of the study
The smaller number of HTx recipients is a lim-
itation which may have prevented identification of
other predictive variables. Furthermore, peak exer-
cise capacity was not measured by cardiopulmonary
exercise testing, which allows identification of pa-
tients not exercising beyond the anaerobic thresh-
old. Because exercise capacity was assessed by tread-
mill exercise in this study, we cannot rule out that
some patients did not exercise to their individual
maximum.
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This study shows that heart rate response is the
most important predictor of exercise capacity in pa-
tients without relevant macroscopic coronary an-
giopathy a long time after HTx.On the basis of our
results, monitoring of exercise capacity is recom-
mended in HTx recipients who are started on nega-
tive chronotropic medication such as b-blockers or
certain calcium antagonists. In addition, heart rate
adaptive pacing should be considered, i.e. when
chronotropic incompetence in combination with
reduced exercise capacity persists more than
6 months after HTx.
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